Cargando…

Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?

PURPOSE: The present study aims to conduct a systematic review of literature reporting on the dose and dosing schedule of dexamethasone (DXM) in relation to clinical outcomes in malignant brain tumor patients, with particular attention to evidence-based practice. METHODS: A systematic search was per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jessurun, Charissa A. C., Hulsbergen, Alexander F. C., Cho, Logan D., Aglio, Linda S., Nandoe Tewarie, Rishi D. S., Broekman, Marike L. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Topic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700052/ https://www.ncbi.nlm.nih.gov/pubmed/31346902 http://dx.doi.org/10.1007/s11060-019-03238-4

Ejemplares similares

Management of hydrocephalus in patients with leptomeningeal metastases: an ethical approach to decision-making
por: Lamba, Nayan, et al.
Publicado: (2018)

72. THE COMBINED USE OF STEROIDS AND IMMUNE CHECKPOINT INHIBITORS IN BRAIN METASTASES PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Jessurun, Charissa, et al.
Publicado: (2020)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysis
por: Tewarie, Ishaan Ashwini, et al.
Publicado: (2021)

67. INCREASED RISK OF BREAST CANCER BRAIN METASTASIS WITH EGFR AND Ki-67 EXPRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Job, Arun, et al.
Publicado: (2020)

Heparin in malignant glioma: review of preclinical studies and clinical results
por: Schnoor, Rosalie, et al.
Publicado: (2015)

Dark matter: what do we really know
por: Tao, C
Publicado: (2013)

Tight glycemic control: what do we really know, and what should we expect?
por: Nasraway, Stanley A, et al.
Publicado: (2010)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

The Science of Soy: What Do We Really Know?
por: Barrett, Julia R.
Publicado: (2006)

Pyorrhea Alveolaris—What Do We Really Know of It
por: Trueman, W. H.
Publicado: (1897)

Mechanisms of injustice: what we (do not) know about racialized disparities in pain
por: Mathur, Vani A., et al.
Publicado: (2022)

Posterior cruciate ligament injuries: what do we really know?
por: Winkler, Philipp W., et al.
Publicado: (2021)

Human cutaneous B cells: what do we really know?
por: Lerman, Irina, et al.
Publicado: (2021)

What Do We Really Know About Neutron Stars?
por: Woltjer, Lodewijk
Publicado: (2003)

Childhood-onset schizophrenia: what do we really know?
por: Bartlett, Jennifer
Publicado: (2014)

Assembly and Turnover of Caveolae: What Do We Really Know?
por: Han, Bing, et al.
Publicado: (2016)

Cancer and COVID-19: what do we really know?
por: Poortmans, Philip M, et al.
Publicado: (2020)

Giant paraesophageal hernia: What do we really know?
por: Bhargava, Amit, et al.
Publicado: (2020)

Appendiceal phlegmon in adults: Do we know how to manage it yet?
por: Panahi, Pedram, et al.
Publicado: (2020)

Effectiveness and practicality of control strategies for African swine fever: what do we really know?
por: Guinat, C., et al.
Publicado: (2017)

Mobile phones in Africa: how much do we really know?
por: James, Jeffrey, et al.
Publicado: (2007)

Psychrotrophic bacteria in milk: How much do we really know?
por: de Oliveira, Gislene B., et al.
Publicado: (2015)

The Physiology of Bone Pain. How Much Do We Really Know?
por: Nencini, Sara, et al.
Publicado: (2016)

Do we really know the duration of pain after rib fracture?
por: Tulay, Cumhur Murat, et al.
Publicado: (2018)

Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
por: Tewarie, Ishaan Ashwini, et al.
Publicado: (2020)

Dietary protein safety and resistance exercise: what do we really know?
por: Lowery, Lonnie M, et al.
Publicado: (2009)

Q&A: Who is H. sapiens really, and how do we know?
por: Liang, Mason, et al.
Publicado: (2011)

Presence of the Neurotoxin BMAA in Aquatic Ecosystems: What Do We Really Know?
por: Faassen, Elisabeth J.
Publicado: (2014)

The fragile X syndrome–autism comorbidity: what do we really know?
por: Abbeduto, Leonard, et al.
Publicado: (2014)

Establishment of latent HIV-1 reservoirs: what do we really know?
por: Vanhamel, Jef, et al.
Publicado: (2019)

Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
por: Cheung, Alison, et al.
Publicado: (2022)

Neuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?
por: Lin, Tong, et al.
Publicado: (2021)

Ethical considerations of neuro-oncology trial design in the era of precision medicine
por: Gupta, Saksham, et al.
Publicado: (2017)

Open Questions: We don’t really know anything, do we? Open questions in sensory biology
por: Johnsen, Sönke
Publicado: (2017)

Robotic Radical Prostatectomy: What Do We Really Know about Its Outcomes?
por: Naselli, Angelo
Publicado: (2016)

Improving primary care management of asthma: do we know what really works?
por: Fletcher, Monica J., et al.
Publicado: (2020)

Connexin 43 in Mitochondria: What Do We Really Know About Its Function?
por: Boengler, Kerstin, et al.
Publicado: (2022)

Long-term outcome after anterior cervical discectomy without fusion
por: Nandoe Tewarie, Rishi D. S., et al.
Publicado: (2007)

Dietary Advanced Glycation End products interacting with the intestinal epithelium: What do we really know?
por: Jansen, Fleur A.C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tfuk1hkhdqud06edmfjeh6f4sp